312 related articles for article (PubMed ID: 12635027)
21. Ganciclovir is associated with low or undetectable Epstein-Barr virus DNA load in cerebrospinal fluid of patients with HIV-related primary central nervous system lymphoma.
Bossolasco S; Falk KI; Ponzoni M; Ceserani N; Crippa F; Lazzarin A; Linde A; Cinque P
Clin Infect Dis; 2006 Feb; 42(4):e21-5. PubMed ID: 16421782
[TBL] [Abstract][Full Text] [Related]
22. Clonality analysis by sequence variation of the latent membrane protein 1 gene in patients with chronic active Epstein-Barr virus infection.
Shibata Y; Hoshino Y; Hara S; Yagasaki H; Kojima S; Nishiyama Y; Morishima T; Kimura H
J Med Virol; 2006 Jun; 78(6):770-9. PubMed ID: 16628581
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus (EBV) latent membrane protein-1-specific cytotoxic T lymphocytes targeting EBV-carrying natural killer cell malignancies.
Demachi-Okamura A; Ito Y; Akatsuka Y; Tsujimura K; Morishima Y; Takahashi T; Kuzushima K
Eur J Immunol; 2006 Mar; 36(3):593-602. PubMed ID: 16479544
[TBL] [Abstract][Full Text] [Related]
24. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
[TBL] [Abstract][Full Text] [Related]
25. Allogeneic peripheral blood stem cell transplantation for the treatment of chronic active Epstein-Barr virus infection.
Fujii N; Takenaka K; Hiraki A; Maeda Y; Ikeda K; Shinagawa K; Ashiba A; Munemasa M; Sunami K; Hiramatsu Y; Ishimaru F; Niiya K; Yoshino T; Harada M
Bone Marrow Transplant; 2000 Oct; 26(7):805-8. PubMed ID: 11042666
[TBL] [Abstract][Full Text] [Related]
26. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
[TBL] [Abstract][Full Text] [Related]
27. Comparison of a LightCycler-based real-time PCR for quantitation of Epstein-Barr viral load in different clinical specimens with semiquantitative PCR.
Krumbholz A; Meerbach A; Zell R; Gruhn B; Henke A; Birch-Hirschfeld E; Wutzler P
J Med Virol; 2006 May; 78(5):598-607. PubMed ID: 16555269
[TBL] [Abstract][Full Text] [Related]
28. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
29. Clinical analysis and follow-up study of chronic active Epstein-Barr virus infection in 53 pediatric cases.
Lu G; Xie ZD; Zhao SY; Ye LJ; Wu RH; Liu CY; Yang S; Jin YK; Shen KL
Chin Med J (Engl); 2009 Feb; 122(3):262-6. PubMed ID: 19236801
[TBL] [Abstract][Full Text] [Related]
30. A case of a long-time survivor with chronic active Epstein-Barr virus infection.
Takeoka Y; Nakao Y; Ueda M; Koh KR; Aoyama Y; Nakamae H; Yamamura R; Ohta K; Takubo T; Yamane T; Hino M; Tokura Y; Ishihara S; Oshima K; Kimura H; Imashuku S
Eur J Haematol; 2004 Jan; 72(1):73-6. PubMed ID: 14962269
[TBL] [Abstract][Full Text] [Related]
31. Incidence of reactive antibodies against epstein-barr in a group of renal transplant patients.
Geramizadeh B; Aghdai M; Azarpira N; Behabahani AB; Heidari T; Banihashemi M; Raisjalali AR; Roozbeh J; Behzadi A
Transplant Proc; 2005 Sep; 37(7):3051-2. PubMed ID: 16213301
[TBL] [Abstract][Full Text] [Related]
32. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus load in cerebrospinal fluid of patients with chronic active Epstein-Barr virus infection.
Ohga S; Sanefuji M; Ishimura M; Nomura A; Torisu H; Kira R; Takada H; Mizuno Y; Kazuyama Y; Hara T
Pediatr Infect Dis J; 2008 Nov; 27(11):1027-30. PubMed ID: 18833029
[TBL] [Abstract][Full Text] [Related]
34. Real-time polymerase chain reaction quantification of human cytomegalovirus and Epstein-Barr virus in periodontal pockets and the adjacent gingiva of periodontitis lesions.
Kubar A; Saygun I; Ozdemir A; Yapar M; Slots J
J Periodontal Res; 2005 Apr; 40(2):97-104. PubMed ID: 15733143
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease.
Kikuta H; Taguchi Y; Tomizawa K; Kojima K; Kawamura N; Ishizaka A; Sakiyama Y; Matsumoto S; Imai S; Kinoshita T
Nature; 1988 Jun; 333(6172):455-7. PubMed ID: 2836734
[TBL] [Abstract][Full Text] [Related]
36. Chronic active Epstein-Barr virus infection in an adult with no detectable immune deficiency.
de Boer M; Mol MJ; Bogman MJ; Galama JM; Raymakers RA
Neth J Med; 2003 Nov; 61(11):376-82. PubMed ID: 14768722
[TBL] [Abstract][Full Text] [Related]
37. Sustained Epstein-Barr virus detection in paediatric liver transplantation. Insights into the occurrence of late PTLD.
D'Antiga L; Del Rizzo M; Mengoli C; Cillo U; Guariso G; Zancan L
Liver Transpl; 2007 Mar; 13(3):343-8. PubMed ID: 17154402
[TBL] [Abstract][Full Text] [Related]
38. Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes.
Comoli P; Pedrazzoli P; Maccario R; Basso S; Carminati O; Labirio M; Schiavo R; Secondino S; Frasson C; Perotti C; Moroni M; Locatelli F; Siena S
J Clin Oncol; 2005 Dec; 23(35):8942-9. PubMed ID: 16204009
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus and rheumatoid arthritis.
Balandraud N; Roudier J; Roudier C
Autoimmun Rev; 2004 Jul; 3(5):362-7. PubMed ID: 15288002
[TBL] [Abstract][Full Text] [Related]
40. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.
Iwatsuki K; Satoh M; Yamamoto T; Oono T; Morizane S; Ohtsuka M; Xu ZG; Suzuki D; Tsuji K
Arch Dermatol; 2006 May; 142(5):587-95. PubMed ID: 16702496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
